Clinical Trial Update: A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial comparing JNJ-42847922 to quetiapine extended-release as adjunctive therapy to antidepressants in adults with major depressive disorder who had an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• JNJ-42847922
• Quetiapine Extended-Release (quetiapine extended-release)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Depressive Disorder, Major | Phase 2 | Status: COMPLETED | Results posted: 2022-08-16